Episode 38 – IV Iron and SGLT2 Inhibitors in Heart Failure (Repeat)

Welcome back Rounds Table Listeners!

We are back with an oldie but a goodie!

In this repeat episode, Drs. Mike and John Fralick do a Rapid Fire session to discuss two papers exploring heart failure – specifically, if intravenous iron or the initiation of SGLT2 inhibitors in hospital for patients with heart failure improves clinical outcomes. Two papers, here we go!

  1. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial (0:00 – 7:18).

  2. The SLGT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial (7:18 – 16:31).

And for the Good Stuff:

Questions? Comments? Feedback? We’d love to hear from you! @roundstable

Leave a Comment

Your email address will not be published. Required fields are marked *

Republish this article

Republish this article on your website under the creative commons licence.

Learn more